AZ logo

AZ

A2Z Cust2Mate Solutions Corp.

$8.16
-$0.09(-1.09%)
58
Overall
--
Value
58
Tech
--
Quality
How is this score calculated?
Market Cap
$367.50M
Volume
523.97K
52W Range
$5.00 - $12.36
Target Price
$22.50

Company Overview

Mkt Cap$367.50MPrice$8.16
Volume523.97KChange-1.09%
P/E Ratio-0.0Open$8.57
Revenue$4.8BPrev Close$8.25
Net Income$-17.0B52W Range$5.00 - $12.36
Div YieldN/ATarget$22.50
Overall58Value--
Quality--Technical58

No chart data available

About A2Z Cust2Mate Solutions Corp.

A2Z Cust2Mate Solutions Corp., a technology company, focuses on the development and commercialization of retail smart cart solutions for grocery stores and supermarkets in Israel and internationally. The company operates through three segments: Precision Metal Parts, Advanced Engineering, and Smart Carts. It offers Cust2Mate system, which incorporates a smart cart that automatically calculates the value of the customers purchases in their smart cart without having to unload and reload their purchases at a customer checkout point. The company also manufactures and sells precision metal parts; provides retail automation solutions; and develops Fuel Tank Inertia Capsule System technology (FTICS), a vehicle device cover for the military and civilian automotive industry. In addition, it provides maintenance services utilizing the application of advanced engineering capabilities to the military and security markets, as well as develops related products for the civilian and retail markets; container leasing services; and maintenance services for complex electronic systems and products. It serves its products to grocery stores, hardware stores, household essentials, do it yourself (DIY) retailers, discount stores, warehouse stores, convenience stores, drug stores, duty free shops, and similar outlets. The company was formerly known as A2Z Smart Technologies Corp. and changed its name to A2Z Cust2Mate Solutions Corp. in August 2024. The company is headquartered in Vancouver, Canada.

Latest News

AstraZeneca Extends Fasenra’s Runway With New Long-Term Safety Study

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. The ROSY-F roll-over study from AstraZeneca (AZN) aims to keep patie...

TipRanks Clinical-Trials-Auto-Generated Newsdeskin 31 minutes

ESPERANZA Update: Real-World Data Study Could Broaden AstraZeneca’s T-DXd Cancer Opportunity

TipRanks Clinical-Trials-Auto-Generated Newsdeskin 28 minutes

RBC Capital Remains a Buy on Jazz Pharmaceuticals (JAZZ)

TipRanks Auto-Generated Intelligence Newsdesk20 hours ago

A2Z Smart Technologies (AZ) Gets a Buy from Northland Securities

TipRanks Auto-Generated Intelligence Newsdeska day ago

UBS Sticks to Its Buy Rating for EBRO FOODS (0NYH)

TipRanks Auto-Generated Intelligence Newsdesk2 days ago
ABCD
1SymbolPriceChangeVol
2AZ$8.16-1.1%523.97K
3
4
5
6

Get A2Z Cust2Mate Solutions Corp. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.